Serial immunoprecipitation assays for interferon – (IFN)-β antibodies in multiple sclerosis patients
Vito Lampasona1, Jordi Rio2, Diego Franciotta3, Roberto Furlan4, Carlo Avolio5, Raffaella Fazio6, Vito Lavolpe7, Angela Vincent8, Giancarlo Comi6, Maria Trojano7, Xavier Montalban2, Gianvito Martino4,6,*
European Cytokine Network, Vol.14, No.3, pp. 154-157, 2003
Abstract We devised a sensitive, radioimmunoprecipitation assay (RIPA) for anti-interferon (IFN)-
b – binding antibody (BAB) detection. Our RIPA showed good agreement with a reference RIPA (mean
difference, – 3.2 ± 10.6 AU), and detected BAB to both IFN-β-1α and IFN-β-1β. Neutralizing antibodies to IFN-β
(NAB) were also determined with a standard method. BAB and NAB were measured in 393 serum samples from
77 multiple sclerosis (MS) patients treated with IFN-β-1α or -1β, who were studied over two years, and
subsequently classified as responders and non-responders. BAB were found at higher concentrations, and more
frequently detected, More >